1
/
of
1
Elabscience
SKU:PKSV030448
Recombinant SARS-CoV-2 Spike RBD(G482S)(His Tag)
Recombinant SARS-CoV-2 Spike RBD(G482S)(His Tag)
Regular price
$1,105.00 USD
Regular price
Sale price
$1,105.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant SARS-CoV-2 Spike RBD(G482S)(His Tag), a cutting-edge product designed to facilitate advanced research and development in the field of virology. This meticulously engineered recombinant protein offers a unique and invaluable tool for studying the Spike Receptor Binding Domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Crafted with utmost precision, the Recombinant SARS-CoV-2 Spike RBD(G482S)(His Tag) showcases an innovative G482S mutation, enabling researchers to delve deeper into the intricate mechanisms of viral entry and host cell interaction. This mutation, coupled with the incorporation of a highly efficient His Tag, ensures enhanced protein stability and ease of purification, thereby streamlining experimental procedures.
With its exceptional purity and bioactivity, this recombinant protein serves as an indispensable asset for elucidating the molecular intricacies of SARS-CoV-2 infection. Its high affinity for the angiotensin-converting enzyme 2 (ACE2) receptor, the primary target of viral attachment, enables comprehensive investigations into viral entry inhibition strategies and the development of potential therapeutic interventions.
The Recombinant SARS-CoV-2 Spike RBD(G482S)(His Tag) is meticulously manufactured in state-of-the-art facilities, adhering to stringent quality control measures to ensure utmost reliability and reproducibility. Each batch undergoes rigorous testing to guarantee exceptional purity, biological activity, and structural integrity, empowering researchers with confidence in their experimental outcomes.
This product is supplied in a convenient lyophilized form, preserving its stability and facilitating long-term storage. Its user-friendly nature allows for effortless reconstitution, ensuring seamless integration into various experimental protocols. Furthermore, the Recombinant SARS-CoV-2 Spike RBD(G482S)(His Tag) is compatible with a wide range of downstream applications, including but not limited to protein-protein interaction studies, vaccine development, and drug screening assays.
In summary, the Recombinant SARS-CoV-2 Spike RBD(G482S)(His Tag) represents a breakthrough in virological research, offering an invaluable tool for unraveling the intricate mechanisms of SARS-CoV-2 infection. With its exceptional purity, bioactivity, and stability, this recombinant protein empowers researchers to advance their understanding of viral pathogenesis and develop novel strategies to combat this global health threat.
Crafted with utmost precision, the Recombinant SARS-CoV-2 Spike RBD(G482S)(His Tag) showcases an innovative G482S mutation, enabling researchers to delve deeper into the intricate mechanisms of viral entry and host cell interaction. This mutation, coupled with the incorporation of a highly efficient His Tag, ensures enhanced protein stability and ease of purification, thereby streamlining experimental procedures.
With its exceptional purity and bioactivity, this recombinant protein serves as an indispensable asset for elucidating the molecular intricacies of SARS-CoV-2 infection. Its high affinity for the angiotensin-converting enzyme 2 (ACE2) receptor, the primary target of viral attachment, enables comprehensive investigations into viral entry inhibition strategies and the development of potential therapeutic interventions.
The Recombinant SARS-CoV-2 Spike RBD(G482S)(His Tag) is meticulously manufactured in state-of-the-art facilities, adhering to stringent quality control measures to ensure utmost reliability and reproducibility. Each batch undergoes rigorous testing to guarantee exceptional purity, biological activity, and structural integrity, empowering researchers with confidence in their experimental outcomes.
This product is supplied in a convenient lyophilized form, preserving its stability and facilitating long-term storage. Its user-friendly nature allows for effortless reconstitution, ensuring seamless integration into various experimental protocols. Furthermore, the Recombinant SARS-CoV-2 Spike RBD(G482S)(His Tag) is compatible with a wide range of downstream applications, including but not limited to protein-protein interaction studies, vaccine development, and drug screening assays.
In summary, the Recombinant SARS-CoV-2 Spike RBD(G482S)(His Tag) represents a breakthrough in virological research, offering an invaluable tool for unraveling the intricate mechanisms of SARS-CoV-2 infection. With its exceptional purity, bioactivity, and stability, this recombinant protein empowers researchers to advance their understanding of viral pathogenesis and develop novel strategies to combat this global health threat.
Share
